These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 9837767

  • 1. Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy.
    Suzuki T, Piche A, Kasono K, Xiang J, Gomez-Navarro J, Moriuchi S, Krisky DM, Oligino T, Glorioso JC, Curiel TJ, Curiel DT.
    Biochem Biophys Res Commun; 1998 Nov 27; 252(3):686-90. PubMed ID: 9837767
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Highly efficient suicide gene expression in hepatocellular carcinoma cells by epstein-barr virus-based plasmid vectors combined with polyamidoamine dendrimer.
    Harada Y, Iwai M, Tanaka S, Okanoue T, Kashima K, Maruyama-Tabata H, Hirai H, Satoh E, Imanishi J, Mazda O.
    Cancer Gene Ther; 2000 Jan 27; 7(1):27-36. PubMed ID: 10678353
    [Abstract] [Full Text] [Related]

  • 4. Effects of bicistronic lentiviral vector-mediated herpes simplex virus thymidine kinase/ganciclovir system on human lens epithelial cells.
    Yang J, Liu TJ, Lu Y.
    Curr Eye Res; 2007 Jan 27; 32(1):33-42. PubMed ID: 17364733
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Polyethylenimine-mediated suicide gene transfer induces a therapeutic effect for hepatocellular carcinoma in vivo by using an Epstein-Barr virus-based plasmid vector.
    Iwai M, Harada Y, Tanaka S, Muramatsu A, Mori T, Kashima K, Imanishi J, Mazda O.
    Biochem Biophys Res Commun; 2002 Feb 15; 291(1):48-54. PubMed ID: 11829460
    [Abstract] [Full Text] [Related]

  • 7. Combined suicide gene and immunostimulatory gene therapy using AAV-mediated gene transfer to HPV-16 transformed mouse cell: decrease of oncogenicity and induction of protection.
    Janousková O, Síma P, Kunke D.
    Int J Oncol; 2003 Mar 15; 22(3):569-77. PubMed ID: 12579310
    [Abstract] [Full Text] [Related]

  • 8. Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma.
    Roychowdhury S, Peng R, Baiocchi RA, Bhatt D, Vourganti S, Grecula J, Gupta N, Eisenbeis CF, Nuovo GJ, Yang W, Schmalbrock P, Ferketich A, Moeschberger M, Porcu P, Barth RF, Caligiuri MA.
    Cancer Res; 2003 Mar 01; 63(5):965-71. PubMed ID: 12615710
    [Abstract] [Full Text] [Related]

  • 9. I kappa B-mediated apoptotic gene therapy against acute myelogenous leukemia using replication-defective HSV-1 vector expressing TK and mutant I kappa B alpha.
    Kuwayama Y, Suzuki T, Moriuchi S, Glorioso JC, Bessho M.
    Cell Mol Biol (Noisy-le-grand); 2005 Sep 02; 51(1):77-86. PubMed ID: 16171566
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus vector-mediated gene transfer into human B cells: potential for antitumor vaccination.
    Hellebrand E, Mautner J, Reisbach G, Nimmerjahn F, Hallek M, Mocikat R, Hammerschmidt W.
    Gene Ther; 2006 Jan 02; 13(2):150-62. PubMed ID: 16136164
    [Abstract] [Full Text] [Related]

  • 11. Human prostate carcinoma cells as targets for herpes simplex virus thymidine kinase-mediated suicide gene therapy.
    Loimas S, Toppinen MR, Visakorpi T, Jänne J, Wahlfors J.
    Cancer Gene Ther; 2001 Feb 02; 8(2):137-44. PubMed ID: 11263529
    [Abstract] [Full Text] [Related]

  • 12. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.
    Moriuchi S, Krisky DM, Marconi PC, Tamura M, Shimizu K, Yoshimine T, Cohen JB, Glorioso JC.
    Gene Ther; 2000 Sep 02; 7(17):1483-90. PubMed ID: 11001368
    [Abstract] [Full Text] [Related]

  • 13. HSV-tk/GCV gene therapy mediated by EBV-LMP1 for EBV-associated cancer.
    Lifang Y, Min T, Midan A, Ya C.
    J Exp Clin Cancer Res; 2008 Sep 23; 27(1):42. PubMed ID: 18811956
    [Abstract] [Full Text] [Related]

  • 14. Combination suicide/cytokine gene therapy as adjuvants to a defective herpes simplex virus-based cancer vaccine.
    Toda M, Martuza RL, Rabkin SD.
    Gene Ther; 2001 Feb 23; 8(4):332-9. PubMed ID: 11313808
    [Abstract] [Full Text] [Related]

  • 15. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
    Howard BD, Boenicke L, Schniewind B, Henne-Bruns D, Kalthoff H.
    Cancer Gene Ther; 2000 Jun 23; 7(6):927-38. PubMed ID: 10880025
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Use of EBV-based Vector/HVJ-liposome complex vector for targeted gene therapy of EBV-associated neoplasms.
    Hirai H, Satoh E, Osawa M, Inaba T, Shimazaki C, Kinoshita S, Nakagawa M, Mazda O, Imanishi J.
    Biochem Biophys Res Commun; 1997 Dec 08; 241(1):112-8. PubMed ID: 9405242
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.